KERALYT (salicylic acid)

There are 2 contraindications. Absolute contraindication.

Contraindication List
Aspirin exacerbated respiratory disease
Hemolytic anemia from pyruvate kinase and g6PD deficiencies

There are 0 severe contraindications.

There are 1 moderate contraindications. Clinically significant contraindication, where the condition can be managed or treated before the drug may be given safely.

Moderate List
Peripheral vascular disease

There are 12 severe adverse reactions.

More Frequent	Less Frequent
None.	None.

Rare/Very Rare
Anaphylaxis Burns Dyspnea Facial edema Hypersensitivity drug reaction Periorbital edema Pharyngeal edema Skin ulcer Superficial skin ulcer Syncope Throat constriction Urticaria

There are 4 less severe adverse reactions.

More Frequent	Less Frequent
Stinging of skin	Dry skin Skin irritation

Rare/Very Rare
Pruritus of skin

There are no adequate and well-controlled studies of topical salicylic acid in pregnant women; the drug should be used during pregnancy only if the potential benefits justify the possible risks to the fetus.

Because of the potential for serious adverse reactions to salicylic acid in nursing infants, a decision should be made whether to discontinue nursing or the drug, taking into account the importance of the drug to the woman. If used in nursing women, the drug should not be applied to the chest area to avoid accidental contamination of the infant.

No enhanced Geriatric Use information available for this drug.